
Micromem: Update on LIBS project
(CSE: MRM, OTCQX: MMTIF) […]
(CSE: MRM, OTCQX: MMTIF) […]
[TSX: NB; OTCQX: NIOBF; and FSE: BR3] […]
NYSE:EDUC […]
Presentations Include Long-Term Selected Side Effect Data for Prostate Cancer; FMEA Quality Assessment for Head and Neck Cancer Utilizing Cesium-131; Primary Management of Gynecologic Malignancies With Cesium-131; and Permanent Brain Brachytherapy Treatment Planning Using Stranded Cesium-131 Seeds […]
(TSX: NB, OTCQX: NIOBF, FSE: BR3) […]
(CSE: MRM, OTCQX: MMTIF) […]
(TSX: NB, OTCQX: NIOBF, FSE: BR3) […]
(CSE: MRM, OTCQX: MMTIF), […]
Interview with Nick Carter, CEO […]
Toronto, New York, March 10, 2015: Micromem Technologies Inc. (“Micromem”) (“the Company”) (CSE: MRM, OTCQX: MMTIF) through its wholly owned subsidiary, Micromem Applied Sensor Technologies Inc. (MAST), is pleased to provide the following update on […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com